MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

89bio, Inc. - Common Stock (NQ:ETNB)

14.84 UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 14.84
Bid (Size) 14.80 (1)
Ask (Size) 14.96 (1)
Prev. Close 14.84
Today's Range 14.84 - 14.84
52wk Range 4.160 - 15.06
Shares Outstanding 75,480,884
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Arcutis Stock Is Up 100% in a Year but Here’s Why One Fund Still Sold 1 Million Shares ↗
Even after cutting back, this remains the fund’s largest bet and the timing lines up with a pivotal stretch for Arcutis’ pipeline. 
Via The Motley Fool
News headline image
Fund Discloses Increased Mineralys Bet Amid 200% Stock Run as New Drug Application Nears ↗
When a clinical-stage biotech is sitting on nearly $600 million in cash and lining up an FDA filing, sharp investors stop arguing about the past rally and start debating what comes next. 
Via The Motley Fool
Topics Regulatory Compliance

Performance

YTD
N/A
N/A
1 Month
N/A
N/A
3 Month
+0.2%
+0.2%
6 Month
+40.5%
+40.5%
1 Year
+100.5%
+100.5%

More News

Read More
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 89bio, Inc. (Nasdaq - ETNB), Barinthus Biotherapeutics plc (Nasdaq - BRNS), Verint Systems Inc. (Nasdaq - VRNT), Dayforce, Inc. (NYSE- DAY)
From Brodsky & Smith LLC
Via GlobeNewswire
89bio Stock Skyrockets After Roche’s $3.5B Buyout Offer: Retail Bullish, But A Wall Street Analyst Is Cautious ↗
Via Stocktwits
News headline image
Why Did Applied Digital Stock Jump Today? ↗
Via The Motley Fool
Topics Artificial Intelligence Stocks
News headline image
Novo Nordisk Bulks Up Its Obesity-Tied Portfolio With $4.7 Billion Buyout ↗
Via Investor's Business Daily
News headline image
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates DAY, BRNS, ETNB, VRNT on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 89bio, Inc. (Nasdaq - ETNB), Barinthus Biotherapeutics plc (Nasdaq - BRNS), Verint Systems Inc. (Nasdaq - VRNT), Dayforce, Inc. (NYSE- DAY)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
89bio Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 89bio, Inc. - ETNB
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PINC, MTSR, ETNB on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PGRE, BERY, COMP, ETNB on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Unusual volume stocks are being observed in Tuesday's session. ↗
Via Chartmill
News headline image
Viking Therapeutics Stock Gets Boost From Pfizer-Metsera Deal, Says BTIG — Retail Slams Rivals For Buying ‘Inferior Pipelines’ ↗
Via Stocktwits
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PGRE, ETNB, STAA on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
In today's session, these stocks are experiencing unusual volume. ↗
Via Chartmill
News headline image
89BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 89bio, Inc. - ETNB
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Deal Dispatch: Need M&A Approval? FCC Chair Explains How To Get It ↗
Via Benzinga
News headline image
This United Parcel Service Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday ↗
Via Benzinga
News headline image
Russell 2000 Hits All-Time Highs: 8 Stocks Power Small-Cap Comeback ↗
Via Benzinga
Topics ETFs Economy
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Via Benzinga
News headline image
Roche To Acquire 89bio For $2.4 Billion In Liver And Cardiometabolic Push ↗
Via Benzinga
News headline image
Here are the top movers in Thursday's session. ↗
Via Chartmill
News headline image
Gold Falls Over 1%; Darden Posts Downbeat Earnings ↗
Via Benzinga
News headline image
Traders are paying attention to the gapping stocks in Thursday's session. ↗
Via Chartmill

Frequently Asked Questions

Is 89bio, Inc. - Common Stock publicly traded?
Yes, 89bio, Inc. - Common Stock is publicly traded.
What exchange does 89bio, Inc. - Common Stock trade on?
89bio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for 89bio, Inc. - Common Stock?
The ticker symbol for 89bio, Inc. - Common Stock is ETNB on the Nasdaq Stock Market
What is the current price of 89bio, Inc. - Common Stock?
The current price of 89bio, Inc. - Common Stock is 14.84
When was 89bio, Inc. - Common Stock last traded?
The last trade of 89bio, Inc. - Common Stock was at 10/29/25 04:00 PM ET
What is the market capitalization of 89bio, Inc. - Common Stock?
The market capitalization of 89bio, Inc. - Common Stock is 1.12B
How many shares of 89bio, Inc. - Common Stock are outstanding?
89bio, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story